QQ客服 官方微博 反馈留言

	Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial
	Steg, Philippe Gabriel; Szarek, Michael; Bhatt, Deepak L.; Bittner, Vera A.; Bregeault, Marie-France; Dalby, Anthony J.; Diaz, Rafael; E 更多
刊名	CIRCULATION
	2019
卷号	140期号:2页码:103-112
关键词	acute coronary syndrome alirocumab cholesterol mortality PCSK9 protein
DOI	10.1161/CIRCULATIONAHA.118.038840
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4550955
专题	山东大学
作者单位	1.Univ Paris, Hop Bichat, Assistance Publ Hop Paris, INSERM,U1148,FACT, Paris, France. 2.Imperial Col
推荐引用方式 GB/T 7714	Steg, Philippe Gabriel,Szarek, Michael,Bhatt, Deepak L.,et al. Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial[J]. CIRCULATION,2019,140(2):103-112.
APA	Steg, Philippe Gabriel.,Szarek, Michael.,Bhatt, Deepak L..,Bittner, Vera A..,Bregeault, Marie-France.,...&E 更多.(2019).Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.CIRCULATION,140(2),103-112.
MLA	Steg, Philippe Gabriel,et al."Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial".CIRCULATION 140.2(2019):103-112.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。